Bellicum Pharmaceuticals Inc reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bellicum Pharmaceuticals Inc using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-31 | $-0.20 | $-0.93 | 78.5 % |
Sep 2022 | 2022-11-10 | $-0.23 | $-0.64 | 64.1 % |
Jun 2022 | 2022-08-11 | $-0.13 | $-0.69 | 81.2 % |
Jun 2021 | 2021-08-12 | $-0.22 | $-1.37 | 83.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2021 | 2021-08-12 | $700.00K | $250.00K | 180.0 % |
Dec 2020 | 2021-03-30 | $500.00K | $250.00K | 100.0 % |
Jun 2020 | 2020-08-06 | $0 | $900.00K | -100.0 % |
Dec 2019 | 2020-03-12 | $133.00K | $630.00K | -78.9 % |
Bellicum Pharmaceuticals Inc (BLCM) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
The Actual EPS was $-0.02, which missed the estimate of $0.00.
The Actual Revenue was $1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.